Stock Events

Stock Events

Enliven Therapeutics (ELVN) Q3 2024 Earnings

13AugConfirmed

Q3 2023

Q4 2023

Q2 2024

Q3 2024

-0.55

-0.5

-0.46

-0.41

Details

Expected EPS

-0.55

Actual EPS

-0.41

Surprise EPS

0.14

Surprise Percent

+25.45%

Description

Enliven Therapeutics (ELVN) has reported earnings of -0.41 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.